Boswellic acid inhibits inflammatory angiogenesis in a murine sponge model

Alibini, 2005, Tumor inflammatory angiogenesis and its chemoprevention, Cancer Res., 65, 10637, 10.1158/0008-5472.CAN-05-3473 Ammon, 1993, Mechanism of anti-inflammatory actions of curcumine and boswellic acids, J. Ethnopharmacol., 38, 113, 10.1016/0378-8741(93)90005-P Appleton, 1996, The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis, J. Pathol., 180, 90, 10.1002/(SICI)1096-9896(199609)180:1<90::AID-PATH615>3.0.CO;2-D Barcelos, 2009, Role of the chemokines. CCL3/MIP-1α and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice, Microvasc. Res., 78, 148, 10.1016/j.mvr.2009.04.009 Belo, 2004, Inhibition of inflammatory angiogenesis by distant subcutaneous tumor in mice, Life Sci., 74, 2827, 10.1016/j.lfs.2003.09.072 Bergheim, 2006, Metformin prevents endotoxininduced liver injury after partial hepatectomy, J. Pharmacol. Exp. Ther., 316, 1053, 10.1124/jpet.105.092122 Campos, 2008, Mechanisms of wound healing responses in lupus-prone New Zealand white mouse strain, Wound Rep. Reg., 16, 416, 10.1111/j.1524-475X.2008.00381.x Chen, 2001, Clinical trials referral resource: current clinical trials of the anti-VEGF monoclonal antibody bevacizumab, Oncology, 15, 1023 Connolly, 1989, Human vascular permeability factor. Isolation from U937 cells, J. Biol. Chem., 264, 20017, 10.1016/S0021-9258(19)47212-8 Dvorak, 2002, Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy, J. Clin. Oncol., 21, 4368, 10.1200/JCO.2002.10.088 Ferreira, 2004, Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO), Br. J. Pharmacol., 141, 1185, 10.1038/sj.bjp.0705731 Folkman, 1971, Tumor angiogenesis: therapeutic implications, N. Engl. J. Med., 285, 1182, 10.1056/NEJM197111182852108 Gerhardt, 2001, Therapie des aktiven Morbus Crohn mit Boswellia serrata extract H 15, Z. Gastroenterol., 39, 11, 10.1055/s-2001-10708 Glaser, 1999, Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity, Br. J. Cancer, 80, 756, 10.1038/sj.bjc.6690419 Gupta, 1997, Effects of Boswellia serrata gum resin in patients with ulcerative colitis, Eur. J. Med. Res., 2, 37 Gupta, 1998, Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a doubleblind, placebo-controlled, 6-week clinical study, Eur. J. Med. Res., 3, 511 Gupta, 2001, Effects of gum resin of Boswellia serrata in patients with chronic colitis, Planta. Med., 67, 391, 10.1055/s-2001-15802 Han, 1994, Highlight on the studies of anticancer drugs derived from plants in China, Stem. Cells, 12, 53, 10.1002/stem.5530120110 Hlkatky, 2002, Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us, J. Natl. Cancer Inst., 94, 883, 10.1093/jnci/94.12.883 Hoernlein, 1999, Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I, J. Pharmacol. Exp. Ther., 288, 613 Hostanska, 2002, Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro, Anticancer Res., 22, 2853 Hu, 1995, Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers, Lab. Invest., 72, 601 Huang, 2000, Anti-tumor and anti-carcinogenic activities of triterpenoid, β-boswellic acid, Biofactors, 13, 225, 10.1002/biof.5520130135 Jing, 1999, Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines, Leuk. Res., 23, 43, 10.1016/S0145-2126(98)00096-4 Kiela, 2005, Effects of Boswellia serrata in mouse models of chemically induced colitis, Am. J. Physiol. Gastrointest. Liver Physiol., 288, G798, 10.1152/ajpgi.00433.2004 Leung, 1989, Vascular endothelial growth factor is a secreted angiogenic mitogen, Science, 246, 1306, 10.1126/science.2479986 Liu, 2002, Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway, Int. J. Mol. Med., 10, 501 Lu, 2008, Acetyl-keto-B-boswellic acid induces apoptosis through a death receptor 5 — mediated pathway in prostate cancer cells, Cancer Res, 68, 1180, 10.1158/0008-5472.CAN-07-2978 Machado, 2000, Opposing actions of angiotensins on angiogenesis, Life Sci., 66, 67, 10.1016/S0024-3205(99)00562-7 Maeda, 1996, Prognostic value of vascular endothelial growth factor expression in gastric carcinoma, Cancer, 77, 858, 10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-A Mendes, 2009, Differential effects of rolipram on chronic subcutaneous inflammatory angiogenesis and on peritoneal adhesion in mice, Microvasc. Res., 78, 265, 10.1016/j.mvr.2009.08.008 Nicosia, 1994, Vascular endothelial growth factor, platelet-derived growth factor and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro, Am. J. Pathol., 145, 1023 Park, 2002, Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2, Adv. Exp. Med. Biol., 507, 387, 10.1007/978-1-4615-0193-0_60 Phillips, 1995, Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea, In Vivo, 8, 961 Plouet, 1989, Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells, EMBO J., 8, 3801, 10.1002/j.1460-2075.1989.tb08557.x Safayhi, 1991, Protection by boswellic acids against galactosamine/endotoxin-induced hepatitis in mice, Biochem. Pharmacol., 41, 1536, 10.1016/0006-2952(91)90575-P Safayhi, 1992, Boswellic acids: novel, specific nonredox inhibitors of 5-lipoxygenase, J. Pharmacol. Exp. Ther., 261, 1143 Safayhi, 1997, Inhibition by boswellic acids of human leukocyte elastase, J. Pharmacol. Exp. Ther., 281, 460 Sailer, 1996, Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity, Br. J. Pharmacol., 117, 615, 10.1111/j.1476-5381.1996.tb15235.x Shao, 1998, Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture, Planta. Med., 64, 328, 10.1055/s-2006-957444 Sharma, 1989, Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis, Int. J. Immunopharmacol., 11, 647, 10.1016/0192-0561(89)90150-1 Sharma, 1996, Immunomodulatory activity of boswellic acids (pentacyclic triterpene acids) from Boswellia serrata, Phytother. Res., 10, 107, 10.1002/(SICI)1099-1573(199603)10:2<107::AID-PTR780>3.0.CO;2-3 Singh, 1986, Pharmacology of an extract of salai guggal ex Boswellia serrata, a new non-steroidal anti-inflammatory agent, Agents Actions, 18, 407, 10.1007/BF01965005 Singh, 2007, Effect of acetyl 11-keto β-boswellic acid on metastatic growth factor responsible for angiogenesis, Vasc. Pharmacol., 46, 333, 10.1016/j.vph.2006.09.008 Syrovets, 2005, Acetylboswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinase, J. Immunol., 174, 498, 10.4049/jimmunol.174.1.498 Toi, 1994, Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer, Jpn. J. Cancer Res, 85, 1045, 10.1111/j.1349-7006.1994.tb02904.x Tolentino, 1996, VEGF is sufficient to produce iris neovascularization and neovascular glaucoma in a non-human primate, Arch. Ophthalmol., 114, 964, 10.1001/archopht.1996.01100140172010 Winking, 2000, Boswellic acids inhibit glioma growth: a new treatment option?, J. Neurooncol., 46, 97, 10.1023/A:1006387010528 Yamaoka, 1991, Acceleration of wound healing by recombinant human basic fibroblast growth factor in a rat sponge-implantation model, Jpn. J. Inflamm., 11, 65 Yancopoulos, 2000, Vascular-specific growth factors and blood vessel formation, Nature, 407, 242, 10.1038/35025215 Zhao, 2003, Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells, Cancer Detec. Prev., 27, 67, 10.1016/S0361-090X(02)00170-8